Elsevier eyes leadership on Brazil medical literature market
Elsevier expects to achieve a leading position on the market of medical literature in Brazil with the planned launch of 85 titles.
From Latin American News Digest
Sao Paolo - 19 April 2004 - Anglo-Dutch publisher Elsevier expects to achieve a leading position on the market of medical literature in Brazil with the planned launch of 85 titles.
For the purpose, the company plans to invest between 6.0 mln Brazilian reals ($2.1 mln/1.7 mln euro) and 8.0 mln reals ($2.8 mln/2.3 mln euro), of which 4.8 mln reals ($1.7 mln/1.4 mln euro) this year, when it plans to launch 20 titles.
The company's main competitors on the Brazilian market will be McGraw-Hill, Interamericana do Brasil and Guanabara Koogan. Elsevier has been present in Brazil since 1976 through Elsevier-Grupo Editorial Campus (http://www.campus.com.br/).
With the launch of a new series of books, the company expects to initially increase its annual revenue to about 70 mln reals ($24.3 mln/20.1 mln euro) from the 60 mln reals ($20.8 mln/17.3 mln euro) generated in 2003.
"Excluding medical books, the number of launches was 200 per year. Now the average should be 230," said Claudio Rothmuller, Elsevier's president in Brazil.
Rothmuller explained that part of the 4.8 mln reals, planned to be invested in 2004, has been earmarked for the launch of a specific medical department with 30 professionals divided in teams of translators, proofreaders and graphic designers, among others.
Elsevier is a global information analytics company that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a world-leading provider of information and analytics to professionals and business customers, in a wide range of industries. www.elsevier.com